Novel transmission-blocking antimalarials identified by high-throughput screening of plasmodium berghei Ookluc (2023)
- Authors:
- USP affiliated authors: BARGIERI, DANIEL YOUSSEF - ICB ; PAIM, JULIANA CALIT - ICB ; GAITAN, XIOMARA ALEXANDRA - ICB
- Unidade: ICB
- DOI: 10.1128/aac.01465-22
- Subjects: PARASITOLOGIA; MALÁRIA; ANTIMALÁRICOS; PLASMODIUM; PLASMODIUM FALCIPARUM; QUIMIOTERÁPICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2023
- Source:
- Título: Antimicrobial Agents and Chemotherapy
- ISSN: 1098-6596
- Volume/Número/Paginação/Ano: v. 67, n. 4, art. e01465-22, 11 p., 2023
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
CALIT, Juliana Calit et al. Novel transmission-blocking antimalarials identified by high-throughput screening of plasmodium berghei Ookluc. Antimicrobial Agents and Chemotherapy, v. 67, n. 4, p. 11 , 2023Tradução . . Disponível em: https://doi.org/10.1128/aac.01465-22. Acesso em: 29 dez. 2025. -
APA
Calit, J. C., Araújo, J. E., Deng, B., Miura, K., Gaitán, X. A., Araújo, M. da S., et al. (2023). Novel transmission-blocking antimalarials identified by high-throughput screening of plasmodium berghei Ookluc. Antimicrobial Agents and Chemotherapy, 67( 4), 11 . doi:10.1128/aac.01465-22 -
NLM
Calit JC, Araújo JE, Deng B, Miura K, Gaitán XA, Araújo M da S, Medeiros JF de, Long CA, Eastman RT, Bargieri DY. Novel transmission-blocking antimalarials identified by high-throughput screening of plasmodium berghei Ookluc [Internet]. Antimicrobial Agents and Chemotherapy. 2023 ; 67( 4): 11 .[citado 2025 dez. 29 ] Available from: https://doi.org/10.1128/aac.01465-22 -
Vancouver
Calit JC, Araújo JE, Deng B, Miura K, Gaitán XA, Araújo M da S, Medeiros JF de, Long CA, Eastman RT, Bargieri DY. Novel transmission-blocking antimalarials identified by high-throughput screening of plasmodium berghei Ookluc [Internet]. Antimicrobial Agents and Chemotherapy. 2023 ; 67( 4): 11 .[citado 2025 dez. 29 ] Available from: https://doi.org/10.1128/aac.01465-22 - Primaquine and chloroquine nano-sized solid dispersion-loaded dissolving microarray patches for the improved treatment of malaria caused by Plasmodium vivax
- Transcriptomics-Guided in silico drug repurposing: identifying new candidates with dual-stage antiplasmodial activity
- Artificial intelligence applied to the rapid identification of new antimalarial candidates with dual‐stage activity
- Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax
- A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants
- Integrative multi-kinase approach for the identification of potent antiplasmodial hts
- Pyrimidine azepine targets the plasmodium bc1 complex and displays multistage antimalarial activit
- Characterisation of the merozoite thrombospondin related anonymous protein (MTRAP) of Plasmodium berghei as a transmission-blocking antigen
- Caracterização da proteína MTRAP de Plasmodium berghei como antígeno de bloqueio da transmissão
- Torin 2 derivative, NCATS-SM3710, has potent multistage antimalarial activity through inhibition of P. falciparum Phosphatidylinositol 4-Kinase (PfPI4KIIIβ)
Informações sobre o DOI: 10.1128/aac.01465-22 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Novel_Transmission-Blocki... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
